Company Overview
Sales
44
Cr
Growth: 36.2%
Profit after Tax
2.75
Cr
Growth:
-27.7%
Unknown Cap
N/A
Cr
P/S:
N/A
Industry P/S: 4.4x
Fundamentals
| Sales (Cr) |
₹ 44 |
| Growth |
36.2% |
| EBITDA |
12.1% |
| P/S |
N/A |
| Dividend |
0.0% |
| P/E |
N/A |
| Book Value |
₹ 16.3 |
| PEG Ratio |
N/A |
| ROE |
34.4% |
| P/B |
N/A |
Shareholding Pattern
Increase
Decrease
No change
The company offers a comprehensive range of healthcare services across many specialities and super specialities, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine et
